Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina in Patients With Normal or Slightly Reduced Left Ventricular Function.

NCT01966042 is registered in ClinicalTrials.gov with CellPraxis Bioengenharia Ltda. as lead sponsor.

NCT NCT01966042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01966042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina in Patients With Normal or Slightly Reduced Left Ventricular Function.
Lead sponsor
CellPraxis Bioengenharia Ltda.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2005
Completion date
December 31, 2012
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory angina